Showing results (121-130 of 162) with videos related to
Sort By:
Pageof 17
Pediatric Blood & Cancer|October 27, 2016
Characteristics and outcomes in children with undifferentiated embryonal sarcoma of the liver: A report from the National Cancer DatabaseYan Shi, Yesenia Rojas, Wei Zhang, et al.ACS Omega|September 19, 2022
Rapid Characterization of Solid Tumors Using Resonant SensorsAndee M Beierle, Colin H Quinn, Hooper R Markert, et al.The Journal of Surgical Research|March 7, 2018
Disparities in fertility-sparing surgery in adolescent and young women with stage I ovarian dysgerminomaLaura L Stafman, Ilan I Maizlin, Matthew Dellinger, et al.Journal of Pediatric Surgery|March 3, 2019
Pediatric gastric adenocarcinoma: A National Cancer Data Base reviewRobert A Tessler, Matthew Dellinger, Morgan K Richards, et al.Scientific Reports|April 17, 2025
Investigation of an oncolytic herpes simplex virus as a potential therapeutic agent for gastroenteropancreatic neuroendocrine neoplasmsColin H Quinn, Janet R Julson, Michael H Erwin, et al.Scientific Reports|December 21, 2017
Whole exome sequencing identified sixty-five coding mutations in four neuroblastoma tumorsAubrey L Miller, Patrick L Garcia, Joseph G Pressey, et al.Scientific Reports|March 17, 2021
PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastomaRaoud Marayati, Laura L Stafman, Adele P Williams, et al.Cancer Gene Therapy|April 17, 2021
CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cellsRaoud Marayati, Laura L Stafman, Adele P Williams, et al.Cell Death & Disease|January 15, 2026
PP2A activation targets MYCN in neuroblastomaNazia Nazam, Shamza Manzoor, Maryam Shaikh, et al.Plos One|March 10, 2021
EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growthLaura V Bownes, Adele P Williams, Raoud Marayati, et al.Pageof 17